Genscript Biotech's (HKG:1548) Nasdaq-listed associate Legend Biotech reported a loss of $125.3 million for the third quarter, a twofold increase from $62.2 million a year ago.
Loss per share was $0.34, compared with $0.17 a year earlier, according to a Wednesday filing with the Hong Kong bourse.
Total revenue for the quarter was $160.2 million, compared with $96 million in the year-ago period.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。